Sorafenib Accord 欧盟 - 丹麦文 - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Ropivacaine "BioQ" 2 mg/ml infusionsvæske, opløsning i administrationssystem 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

ropivacaine "bioq" 2 mg/ml infusionsvæske, opløsning i administrationssystem

bioq pharma b.v. - ropivacainhydrochloridmonohydrat - infusionsvæske, opløsning i administrationssystem - 2 mg/ml

Sertralin "Accord" 50 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

sertralin "accord" 50 mg filmovertrukne tabletter

accord healthcare b.v. - sertralinhydrochlorid - filmovertrukne tabletter - 50 mg